<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02634957</url>
  </required_header>
  <id_info>
    <org_study_id>PRO15120009</org_study_id>
    <nct_id>NCT02634957</nct_id>
  </id_info>
  <brief_title>Impact of Duration Of Absolute Voice Rest on Voice Outcome After Phonomicrosurgery</brief_title>
  <official_title>Impact of Duration Of Absolute Voice Rest on Voice Outcome After Phonomicrosurgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Absolute voice rest is commonly prescribed after vocal fold surgery, also known as&#xD;
      phonomicrosurgery, for benign vocal fold lesions. This is thought to decrease scarring of&#xD;
      vocal folds, which could result in increasing tissue stiffness and limitations in optimal&#xD;
      vocal outcome. Unfortunately there is no standardized protocol as to how long patients should&#xD;
      rest their voice after phonomicrosurgery. To date, there are no studies in the literature&#xD;
      directly comparing the impact of short-term and long-term voice rest on vocal fold healing&#xD;
      and voice outcome after phonomicrosurgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine whether 3 days versus 7 days of absolute voice rest&#xD;
      will result in different voice outcomes in patients who have undergone phonomicrosurgery for&#xD;
      benign vocal fold lesions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Due to change in available resources&#xD;
  </why_stopped>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">January 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Voice Handicap Index - 10</measure>
    <time_frame>3 months post op</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Voice Handicap Index - 10</measure>
    <time_frame>1 month post op</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cepstral Peak Prominence (CPP)</measure>
    <time_frame>1 month and 3 months post op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average phonatory airflow in all voiced sentence</measure>
    <time_frame>1 month and 3 months post op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>video stroboscopy findings</measure>
    <time_frame>1 month and 3 months post op</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Benign Neoplasm of True Vocal Cords</condition>
  <arm_group>
    <arm_group_label>3 day absolute voice rest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants would begin initiation of voice/speaking 3 days post phonomicrosurgery for benign vocal fold lesions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7 day absolute voice rest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants would begin initiation of voice/speaking 7 days post phonomicrosurgery for benign vocal fold lesions</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>absolute voice rest</intervention_name>
    <description>absolute voice rest is the complete elimination of any vocalization (no sounds, speaking or whispering)</description>
    <arm_group_label>3 day absolute voice rest</arm_group_label>
    <arm_group_label>7 day absolute voice rest</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with benign mid membranous vocal fold lesions such as the following:&#xD;
&#xD;
               1. Polyps&#xD;
&#xD;
               2. Cysts&#xD;
&#xD;
               3. Sub-epithelial fibrous mass&#xD;
&#xD;
          2. Undergoing elective phonomicrosurgery for vocal fold lesions, which involves microflap&#xD;
             excision +/- truncation +/- steroid injection into the vocal folds.&#xD;
&#xD;
          3. Age 18 and older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients with any of the following will be excluded from the study:&#xD;
&#xD;
          1. Reinke's edema&#xD;
&#xD;
          2. Active smokers&#xD;
&#xD;
          3. Ligamentous mid membranous vocal fold lesions&#xD;
&#xD;
          4. RRP (Recurrent Respiratory Papillomatosis)&#xD;
&#xD;
          5. Dysplasia&#xD;
&#xD;
          6. CIS (Carcinoma-in-situ)&#xD;
&#xD;
          7. SCC (squamous cell carcinoma)&#xD;
&#xD;
          8. Extent of surgery exceeds what is mentioned in the inclusion criteria (e.g., CO2&#xD;
             laser, balloon dilatation, vocal fold augmentation in addition to phonomicrosurgery)&#xD;
&#xD;
          9. Previous vocal fold surgery&#xD;
&#xD;
         10. Systemic steroids&#xD;
&#xD;
         11. History of systemic illness that could affect wound healing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Libby Smith, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 11, 2015</study_first_submitted>
  <study_first_submitted_qc>December 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2015</study_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Libby Smith DO</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>phonomicrosurgery</keyword>
  <keyword>benign vocal fold lesions</keyword>
  <keyword>voice rest</keyword>
  <keyword>vhi-10</keyword>
  <keyword>CPP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>de-identified information with outside collaborators</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>information may be shared during and after collection for the purpose of analysis</ipd_time_frame>
    <ipd_access_criteria>if not part of original IRB, sharing will only occur if there is a data use agreement executed.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

